You have 9 free searches left this month | for more free features.

Condition

Non Small Cell Lung Cancer (1)

Nonsmall Cell Lung Cancer (1)

Overall Status

Active, not recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd. (2)

Collaborator

Intervention

hs-10296 (2)

gefitinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

hs-10296

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)

Active, not recruiting

Nonsmall Cell Lung Cancer

HS-10296

Anaheim, California
+9 more

Dec 27, 2022

Non Small Cell Lung Cancer Trial in Beijing (HS-10296, Gefitinib)

Active, not recruiting

Non Small Cell Lung Cancer

HS-10296
Gefitinib

Beijing, China

Beijing Cancer Hospital

Jan 19, 2022